Cardiac Drug Safety: a Bench to Bedside Approach
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Singapore
World Scientific
2012
|
| Schlagworte: | |
| Beschreibung: | Variability of repolarization Print version record |
| Beschreibung: | 1 online resource (189 pages) |
| ISBN: | 9789814317467 9814317462 1280669225 9781280669224 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045344849 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181206s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 9789814317467 |9 978-981-4317-46-7 | ||
| 020 | |a 9814317462 |9 981-4317-46-2 | ||
| 020 | |a 1280669225 |9 1-280-66922-5 | ||
| 020 | |a 9781280669224 |9 978-1-280-66922-4 | ||
| 035 | |a (ZDB-4-ENC)ocn794328376 | ||
| 035 | |a (OCoLC)794328376 | ||
| 035 | |a (DE-599)BVBBV045344849 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.71 | |
| 082 | 0 | |a 363.738/74 | |
| 082 | 0 | |a 363.73874 | |
| 100 | 1 | |a Killeen, Matthew J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Cardiac Drug Safety |b a Bench to Bedside Approach |
| 264 | 1 | |a Singapore |b World Scientific |c 2012 | |
| 300 | |a 1 online resource (189 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Variability of repolarization | ||
| 500 | |a Print version record | ||
| 505 | 8 | |a Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING / Environmental / Pollution Control |2 bisacsh | |
| 650 | 7 | |a Arrhythmia / Treatment |2 fast | |
| 650 | 7 | |a Drugs / Safety regulations |2 fast | |
| 650 | 7 | |a Cardiovascular Diseases |2 hilcc | |
| 650 | 7 | |a Medicine |2 hilcc | |
| 650 | 7 | |a Health & Biological Sciences |2 hilcc | |
| 650 | 4 | |a Heart / drug effects | |
| 650 | 4 | |a Drug-Related Side Effects and Adverse Reactions / prevention & control | |
| 650 | 4 | |a Arrhythmia |x Treatment |a Drugs |x Safety regulations |z Canada | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Killeen, Matthew J. |t Cardiac Drug Safety : A Bench to Bedside Approach |d Singapore : World Scientific, 2012 |z 9789814317450 |
| 912 | |a ZDB-4-ENC | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030731552 | ||
Datensatz im Suchindex
| _version_ | 1804179164978216960 |
|---|---|
| any_adam_object | |
| author | Killeen, Matthew J. |
| author_facet | Killeen, Matthew J. |
| author_role | aut |
| author_sort | Killeen, Matthew J. |
| author_variant | m j k mj mjk |
| building | Verbundindex |
| bvnumber | BV045344849 |
| collection | ZDB-4-ENC |
| contents | Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr |
| ctrlnum | (ZDB-4-ENC)ocn794328376 (OCoLC)794328376 (DE-599)BVBBV045344849 |
| dewey-full | 615.71 363.738/74 363.73874 |
| dewey-hundreds | 600 - Technology (Applied sciences) 300 - Social sciences |
| dewey-ones | 615 - Pharmacology and therapeutics 363 - Other social problems and services |
| dewey-raw | 615.71 363.738/74 363.73874 |
| dewey-search | 615.71 363.738/74 363.73874 |
| dewey-sort | 3615.71 |
| dewey-tens | 610 - Medicine and health 360 - Social problems and services; associations |
| discipline | Soziologie Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02414nmm a2200505zc 4500</leader><controlfield tag="001">BV045344849</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181206s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789814317467</subfield><subfield code="9">978-981-4317-46-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9814317462</subfield><subfield code="9">981-4317-46-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1280669225</subfield><subfield code="9">1-280-66922-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781280669224</subfield><subfield code="9">978-1-280-66922-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-ENC)ocn794328376</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)794328376</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045344849</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.71</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">363.738/74</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">363.73874</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Killeen, Matthew J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiac Drug Safety</subfield><subfield code="b">a Bench to Bedside Approach</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">World Scientific</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (189 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Variability of repolarization</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING / Environmental / Pollution Control</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arrhythmia / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Safety regulations</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="2">hilcc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">hilcc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Health & Biological Sciences</subfield><subfield code="2">hilcc</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart / drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug-Related Side Effects and Adverse Reactions / prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arrhythmia</subfield><subfield code="x">Treatment</subfield><subfield code="a">Drugs</subfield><subfield code="x">Safety regulations</subfield><subfield code="z">Canada</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Killeen, Matthew J.</subfield><subfield code="t">Cardiac Drug Safety : A Bench to Bedside Approach</subfield><subfield code="d">Singapore : World Scientific, 2012</subfield><subfield code="z">9789814317450</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-ENC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030731552</subfield></datafield></record></collection> |
| id | DE-604.BV045344849 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:15:31Z |
| institution | BVB |
| isbn | 9789814317467 9814317462 1280669225 9781280669224 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030731552 |
| oclc_num | 794328376 |
| open_access_boolean | |
| physical | 1 online resource (189 pages) |
| psigel | ZDB-4-ENC |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | World Scientific |
| record_format | marc |
| spelling | Killeen, Matthew J. Verfasser aut Cardiac Drug Safety a Bench to Bedside Approach Singapore World Scientific 2012 1 online resource (189 pages) txt rdacontent c rdamedia cr rdacarrier Variability of repolarization Print version record Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr MEDICAL / Pharmacology bisacsh TECHNOLOGY & ENGINEERING / Environmental / Pollution Control bisacsh Arrhythmia / Treatment fast Drugs / Safety regulations fast Cardiovascular Diseases hilcc Medicine hilcc Health & Biological Sciences hilcc Heart / drug effects Drug-Related Side Effects and Adverse Reactions / prevention & control Arrhythmia Treatment Drugs Safety regulations Canada Erscheint auch als Druck-Ausgabe Killeen, Matthew J. Cardiac Drug Safety : A Bench to Bedside Approach Singapore : World Scientific, 2012 9789814317450 |
| spellingShingle | Killeen, Matthew J. Cardiac Drug Safety a Bench to Bedside Approach Ensuring the safety of new medical products remains a major challenge for the pharmaceutical industry. Cardiac safety, particularly drug-induced heart rhythm abnormalities, remains an important cause of pipeline attrition and has resulted in countless major product recalls or label changes. The risk of encountering this major adverse event continues to shape the drug development and regulatory landscape. Extensive research over the past decade has shed light on the root causes of arrhythmias that are triggered by medications and has helped drive, and optimize, drug safety testing. However, curr MEDICAL / Pharmacology bisacsh TECHNOLOGY & ENGINEERING / Environmental / Pollution Control bisacsh Arrhythmia / Treatment fast Drugs / Safety regulations fast Cardiovascular Diseases hilcc Medicine hilcc Health & Biological Sciences hilcc Heart / drug effects Drug-Related Side Effects and Adverse Reactions / prevention & control Arrhythmia Treatment Drugs Safety regulations Canada |
| title | Cardiac Drug Safety a Bench to Bedside Approach |
| title_auth | Cardiac Drug Safety a Bench to Bedside Approach |
| title_exact_search | Cardiac Drug Safety a Bench to Bedside Approach |
| title_full | Cardiac Drug Safety a Bench to Bedside Approach |
| title_fullStr | Cardiac Drug Safety a Bench to Bedside Approach |
| title_full_unstemmed | Cardiac Drug Safety a Bench to Bedside Approach |
| title_short | Cardiac Drug Safety |
| title_sort | cardiac drug safety a bench to bedside approach |
| title_sub | a Bench to Bedside Approach |
| topic | MEDICAL / Pharmacology bisacsh TECHNOLOGY & ENGINEERING / Environmental / Pollution Control bisacsh Arrhythmia / Treatment fast Drugs / Safety regulations fast Cardiovascular Diseases hilcc Medicine hilcc Health & Biological Sciences hilcc Heart / drug effects Drug-Related Side Effects and Adverse Reactions / prevention & control Arrhythmia Treatment Drugs Safety regulations Canada |
| topic_facet | MEDICAL / Pharmacology TECHNOLOGY & ENGINEERING / Environmental / Pollution Control Arrhythmia / Treatment Drugs / Safety regulations Cardiovascular Diseases Medicine Health & Biological Sciences Heart / drug effects Drug-Related Side Effects and Adverse Reactions / prevention & control Arrhythmia Treatment Drugs Safety regulations Canada |
| work_keys_str_mv | AT killeenmatthewj cardiacdrugsafetyabenchtobedsideapproach |